Feasibility of clinical pharmacist-led CYP2C19 genotyping for patients receiving non-emergent cardiac catheterization in an integrated health system

• Main Authors: Johnson SG (Author), Shaw PB (Author), Delate T (Author), Kurz DL (Author), Gregg D (Author), Darnell JC (Author), Aquilante CL (Author)
• Format: Book
• Published: Centro de Investigaciones y Publicaciones Farmaceuticas, 2017-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: To assess the feasibility of clinical pharmacist-led CYP2C19 genotype-guided P2Y12 inhibitor antiplatelet drug therapy recommendations to cardiologists in an outpatient cardiology practice. Methods: This was a prospective, open-labeled, single-arm study conducted in an integrated healthca...